Search results
Results from the WOW.Com Content Network
Amblyopia. Anisometropia is a condition in which a person's eyes have substantially differing refractive power. [ 1] Generally, a difference in power of one diopter (1D) is the threshold for diagnosis of the condition. [ 2][ 3] Patients may have up to 3D of anisometropia before the condition becomes clinically significant due to headache, eye ...
Atropine, a tropane alkaloid, is an enantiomeric mixture of d - hyoscyamine and l -hyoscyamine, with most of its physiological effects due to l -hyoscyamine. Its pharmacological effects are due to binding to muscarinic acetylcholine receptors. It is an antimuscarinic agent.
Medications are used to reverse the symptoms of extrapyramidal side effects caused by antipsychotics or other drugs, by either directly or indirectly increasing dopaminergic neurotransmission. The treatment varies by the type of the EPS, but may involve anticholinergic agents such as procyclidine , benztropine , diphenhydramine , and ...
Cycloplegia is paralysis of the ciliary muscle of the eye, resulting in a loss of accommodation. [ 1] Because of the paralysis of the ciliary muscle, the curvature of the lens can no longer be adjusted to focus on nearby objects. This results in similar problems as those caused by presbyopia, in which the lens has lost elasticity and can also ...
Gabapentin, sold under the brand name Neurontin among others, is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain. [ 7][ 10] It is a commonly used medication for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central pain. [ 11]
Atomoxetine. Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor medication used to treat attention deficit hyperactivity disorder (ADHD) [ 12] and, to a lesser extent, cognitive disengagement syndrome. [ 13][ 14][ 15] It may be used alone or along with psychostimulants. [ 16][ 17] It enhances the ...
Monofixation syndrome ( MFS) (also: microtropia or microstrabismus) is an eye condition defined by less-than-perfect binocular vision. [1] It is defined by a small angle deviation with suppression of the deviated eye and the presence of binocular peripheral fusion. [2] That is, MFS implies peripheral fusion without central fusion.
Clobazam, sold under the brand names Frisium, Onfi and others, is a benzodiazepine class medication that was patented in 1968. [ 3] Clobazam was first synthesized in 1966 and first published in 1969. Clobazam was originally marketed as an anxioselective anxiolytic since 1970, [ 4][ 5] and an anticonvulsant since 1984. [ 6]